Organization · Private Equity
Impilo
Impilo is a Nordic private equity investment company focused on the pharmaceutical, medical technology, and healthcare services sectors. They prioritize investments that contribute to sustainable development in the communities they serve.
Overview
What Impilo does
What Impilo is
Impilo is a Nordic private equity investment company focused on the pharmaceutical, medical technology, and healthcare services sectors. They prioritize investments that contribute to sustainable development in the communities they serve.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Private Equity
- Structured capabilities
- Funder
- Last reviewed
- March 4, 2026
Official channels
Find Impilo elsewhere
Open the official website or a supported primary organization account.
Capability profile
Impilo as a funder
Investment thesis
Impilo targets investments in companies that positively impact health and contribute to sustainable healthcare systems. The focus is on private majority investments with significant enterprise values.
Focus narrative
Impilo focuses on investments that have a positive health impact and enhance the sustainability of healthcare systems. They primarily seek private majority investments with enterprise values between EUR 50 million and EUR 200 million, while also considering minority and public investments under certain governance conditions.
Terms and economics
- Typical check
- $50,000,000–$200,000,000
Focus and fit
Availability
- Currently deploying
- Not published
Portfolio and track record
Portfolio context
Notable portfolio companies include Immedica, which specializes in orphan and niche specialty pharmaceuticals; Humana, a leading Nordic private care provider; Euro Accident, a specialist in health-related insurance; and Scantox, a pre-clinical contract research organization. Other companies include tandlægen.dk, Lowenco, Pelago Bioscience, VaccinDirekt, Decon, Avia Pharma, and Stille.
Common questions
What to know about Impilo
Upseed classifies Impilo under the Private Equity organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 4, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.